Kara Carter

1.1k total citations
17 papers, 670 citations indexed

About

Kara Carter is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Kara Carter has authored 17 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Immunology and 4 papers in Infectious Diseases. Recurrent topics in Kara Carter's work include interferon and immune responses (3 papers), Mosquito-borne diseases and control (3 papers) and Herpesvirus Infections and Treatments (3 papers). Kara Carter is often cited by papers focused on interferon and immune responses (3 papers), Mosquito-borne diseases and control (3 papers) and Herpesvirus Infections and Treatments (3 papers). Kara Carter collaborates with scholars based in United States, France and Belgium. Kara Carter's co-authors include Elliott Kieff, Ellen Cahir-McFarland, Louis M. Staudt, Andreas Rosenwald, Jena M. Giltnane, Sarah E. Henrickson, Teresa I. Ng, Bernard Roizman, William O. Ogle and Grégory Neveu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Journal of Hepatology.

In The Last Decade

Kara Carter

16 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kara Carter United States 10 267 237 222 189 121 17 670
Prasanna M. Bhende United States 9 394 1.5× 199 0.8× 235 1.1× 126 0.7× 134 1.1× 10 631
Donato Calista Italy 15 395 1.5× 242 1.0× 320 1.4× 118 0.6× 99 0.8× 46 987
Meir Shamay United States 15 436 1.6× 463 2.0× 349 1.6× 114 0.6× 101 0.8× 31 912
Horng-Shen Chen United States 11 470 1.8× 356 1.5× 151 0.7× 113 0.6× 116 1.0× 12 647
David N. Everly United States 14 364 1.4× 482 2.0× 388 1.7× 335 1.8× 132 1.1× 18 1.0k
Amy L. Adamson United States 13 484 1.8× 280 1.2× 319 1.4× 226 1.2× 143 1.2× 18 867
Tadamasa Ooka France 19 568 2.1× 320 1.4× 149 0.7× 186 1.0× 188 1.6× 28 833
Liang Wei Wang United States 9 262 1.0× 153 0.6× 203 0.9× 129 0.7× 98 0.8× 17 529
Hongyi Pan United States 12 394 1.5× 301 1.3× 326 1.5× 95 0.5× 80 0.7× 21 861
Deguang Liang China 16 474 1.8× 373 1.6× 237 1.1× 166 0.9× 87 0.7× 19 746

Countries citing papers authored by Kara Carter

Since Specialization
Citations

This map shows the geographic impact of Kara Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara Carter more than expected).

Fields of papers citing papers by Kara Carter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kara Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara Carter. The network helps show where Kara Carter may publish in the future.

Co-authorship network of co-authors of Kara Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Kara Carter. A scholar is included among the top collaborators of Kara Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kara Carter. Kara Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Spengler, Jessica R., Kara Carter, Leen Delang, et al.. (2023). Meeting report: 36th International Conference on Antiviral Research in Lyon, France – March 13–17, 2023. Antiviral Research. 217. 105678–105678. 1 indexed citations
3.
Julander, Justin G., Nicole D. Anderson, Nicole N. Haese, et al.. (2022). Therapeutic and prophylactic treatment with a virus-specific antibody is highly effective in rodent models of Chikungunya infection and disease. Antiviral Research. 202. 105295–105295. 4 indexed citations
4.
Spengler, Jessica R., Stephen R. Welch, Andrea Brancale, et al.. (2022). Meeting report: 35th International Conference on Antiviral Research in Seattle, Washington, USA – March 21–25, 2022. Antiviral Research. 211. 105521–105521. 6 indexed citations
5.
Martínez, María Guadalupe, Emmanuel Combe, Philippe Mangeot, et al.. (2022). CRISPR-Cas9 Targeting of Hepatitis B Virus Covalently Closed Circular DNA Generates Transcriptionally Active Episomal Variants. mBio. 13(2). e0288821–e0288821. 28 indexed citations
6.
Brancale, Andrea, Kara Carter, Leen Delang, et al.. (2022). Meeting report: 34th international conference on antiviral research. Antiviral chemistry & chemotherapy. 30. 1125716716–1125716716. 3 indexed citations
7.
Rivoire, Michel, Grégory Neveu, Antoine Alam, et al.. (2020). Full-length 5'RACE identifies all major HBV transcripts in HBV-infected hepatocytes and patient serum. Journal of Hepatology. 73(1). 40–51. 60 indexed citations
8.
Grobler, Jay A., Annaliesa S. Anderson, Prabhavathi Fernandes, et al.. (2020). Accelerated Preclinical Paths to Support Rapid Development of COVID-19 Therapeutics. Cell Host & Microbe. 28(5). 638–645. 25 indexed citations
9.
Martínez, María Guadalupe, Grégory Neveu, Antoine Alam, et al.. (2020). Targeting hepatitis B virus with CRISPR/Cas9 approach. Journal of Hepatology. 73. S841–S842. 3 indexed citations
10.
Bray, Mike, Graciela Andreï, Ester Ballana, et al.. (2018). Meeting report: 31st International Conference on Antiviral Research. Antiviral Research. 158. 88–102. 8 indexed citations
11.
Andreï, Graciela, Kara Carter, Zlatko Janeba, et al.. (2017). Highlights of the 30th International Conference on Antiviral Research. Antiviral Research. 145. 184–196. 10 indexed citations
12.
Byrne, Annette T., Paul Mason, Michael R. Dufault, et al.. (2009). Knockdown of human deubiquitinase PSMD14 induces cell cycle arrest and senescence. Experimental Cell Research. 316(2). 258–271. 54 indexed citations
13.
Rainio, Eeva-Marja, Helena Ahlfors, Kara Carter, et al.. (2005). Pim kinases are upregulated during Epstein–Barr virus infection and enhance EBNA2 activity. Virology. 333(2). 201–206. 30 indexed citations
14.
Cahir-McFarland, Ellen, Kara Carter, Andreas Rosenwald, et al.. (2004). Role of NF-κB in Cell Survival and Transcription of Latent Membrane Protein 1-Expressing or Epstein-Barr Virus Latency III-Infected Cells. Journal of Virology. 78(8). 4108–4119. 196 indexed citations
15.
Wojtowicz, Woj M., Michael Farzan, John L. Joyal, et al.. (2002). Stimulation of Enveloped Virus Infection by β-Amyloid Fibrils. Journal of Biological Chemistry. 277(38). 35019–35024. 59 indexed citations
16.
Carter, Kara, Ellen Cahir-McFarland, & Elliott Kieff. (2002). Epstein-Barr Virus-Induced Changes in B-Lymphocyte Gene Expression. Journal of Virology. 76(20). 10427–10436. 127 indexed citations
17.
Ogle, William O., Teresa I. Ng, Kara Carter, & Bernard Roizman. (1997). The UL13 Protein Kinase and the Infected Cell Type Are Determinants of Posttranslational Modification of ICP0. Virology. 235(2). 406–413. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026